Drug Markets/Lamivudine and Zidovudine

Lamivudine and Zidovudine

5 NDCs across 5 manufacturers|4 Generic,1 Brand

▸ More about this market

Lamivudine and Zidovudine is available as 5 NDCs from 5 manufacturers (4 generic, 1 brand), with NADAC prices from $0.74 to $14.39 per EA — the most expensive product costs about 20× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4G / 1B

Manufacturers

competing in market

Price Spread

$0.74 – $14.39

per EA

7d Activity

9↑-4 flat

avg +2.2% WoW · of 5 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

5 manufacturers producing LAMIVUDINE AND ZIDOVUDINE(1 pricing outlier)

ViiV Healthcare Company

Exelan Pharmaceuticals Inc.

1 NDC

$1.2739

avg/unit

Camber Pharmaceuticals Inc.

1 NDC

$0.7351

avg/unit

Macleods Pharmaceuticals Limited

1 NDC

$0.7351

avg/unit

Aurobindo Pharma Limited

1 NDC

$0.7351

avg/unit

Drug Portfolio

5 NDCs total, 5 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
COMBIVIR TABLET	49702020218	ViiV Healthcare Company	$14.3948 per EA	High Outlier	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
LAMIVUDINE-ZIDOVUDINE TABLET	76282011560	Exelan Pharmaceuticals Inc.	$1.2739 per EA	—	Generic	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
LAMIVUDINE-ZIDOVUDINE TABLET	31722050660	Camber Pharmaceuticals Inc.	$0.7351 per EA	—	Generic	+2.16%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
LAMIVUDINE-ZIDOVUDINE TABLET	33342000309	Macleods Pharmaceuticals Limited	$0.7351 per EA	—	Generic	+2.16%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
LAMIVUDINE-ZIDOVUDINE TABLET	65862003660	Aurobindo Pharma Limited	$0.7351 per EA	—	Generic	+2.16%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Frequently Asked Questions

How many Lamivudine and Zidovudine products are on the market?

The Lamivudine and Zidovudine drug market contains 5 NDCs from 5 manufacturers — 4 generic and 1 brand product.

What is the price range for Lamivudine and Zidovudine?

NADAC reference prices for Lamivudine and Zidovudine range from $0.7351 to $14.3948 per EA — the most expensive product costs about 20× the cheapest.

Is generic Lamivudine and Zidovudine cheaper than brand?

The average generic NADAC for Lamivudine and Zidovudine is $0.8698 per EA, versus $14.3948 for brand-labeled products — brand versions average about 17× the generic price.

Which manufacturers make Lamivudine and Zidovudine?

5 manufacturers list Lamivudine and Zidovudine in NADAC. Ranked by number of NDCs, the largest are ViiV Healthcare Company (1), Exelan Pharmaceuticals Inc. (1), Camber Pharmaceuticals Inc. (1), Macleods Pharmaceuticals Limited (1), Aurobindo Pharma Limited (1).

How has the price of Lamivudine and Zidovudine changed recently?

Over the past 7 days, 9 Lamivudine and Zidovudine NDCs rose and 0 fell, with a market-wide average change of +2.2%.